Multidrug resistant Acinetobacter baumannii: A study on its pathogenesis and therapeutics
Authors:
Open Access
- 6 December 2024
- journal article
- research article
- Published by Elsevier in Current Research in Microbial Sciences
- Vol. 8, 100331
Abstract
No abstract availableKeywords
This publication has 202 references indexed in Scilit:
- Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitorsCell Reports, 2021
- Eradication of Acinetobacter baumannii Planktonic and Biofilm Cells Through Erythrosine-Mediated Photodynamic Inactivation Augmented by Acetic Acid and ChitosanCurrent Microbiology, 2021
- Molecular characterization and epitope-based vaccine predictions for ompA gene associated with biofilm formation in multidrug-resistant strains of A.baumanniiIn Silico Pharmacology, 2021
- DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infectionMolecular Biology Reports, 2019
- Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumanniiLasers in Medical Science, 2019
- Mechanisms of Lung Fibrosis ResolutionThe American Journal of Pathology, 2016
- Task force on management and prevention of Acinetobacter baumannii infections in the ICUIntensive Care Medicine, 2015
- Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patientsAmerican Journal of Infection Control, 2013
- Zingiber officinale (ginger) compounds have tetracycline‐resistance modifying effects against clinical extensively drug‐resistant Acinetobacter baumanniiPhytotherapy Research, 2010
- Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cellsBiochemical Pharmacology, 2007